HaemAnalytica, founded by Prof. Jon Gibbins and Assoc. Prof. Chris Jones spun out from the University of Reading with a seed investment from the University. HaemAnalytica was established to develop platelet technologies, initially designed in the platelet research lab at the university, with 20+ years of grant support from the British Heart Foundation.
With support from our CEO, William Kilgallon, who has over 30 years of experience in the pharmaceutical and diagnostic sectors; our COO, Gemma Little, who has over 10 years of platelet experience; and our CFO, Jeremy Rowson, who has extensive experience with business development and investment with both private and public companies. HaemAnalytica will revolutionise precision medicine using novel platelet assays to add value at all phases of the life sciences value chain from drug discovery to clinic.
